Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2021-06-07 4:04 pm Purchase | 13G | FIGS Inc. FIGS | VIKING GLOBAL INVESTORS LP | 14,942,689 10.12% | 14,942,689 (New Position) | View |
2021-05-17 1:25 pm Purchase | 13G | TOURMALINE BIO INC TRML | VIKING GLOBAL INVESTORS LP | 3,289,617 8.2% | 3,289,617 (New Position) | View |
2021-04-16 2:29 pm Purchase | 13G | Mudrick Capital Acquisition Corp. II MUDS | VIKING GLOBAL INVESTORS LP | 3,047,904 9.6% | 3,047,904 (New Position) | View |
2021-04-05 3:20 pm Purchase | 13G | Edgewise Therapeutics Inc. EWTX | VIKING GLOBAL INVESTORS LP | 3,352,281 7% | 3,352,281 (New Position) | View |
2021-03-12 3:37 pm Purchase | 13G | Orion Acquisition Corp. OHPA | VIKING GLOBAL INVESTORS LP | 3,600,000 8.7% | 3,600,000 (New Position) | View |
2021-02-12 8:02 pm Purchase | 13G | PHARVARIS N V REGISTERED PHVS | VIKING GLOBAL INVESTORS LP | 2,420,155 7.6% | 2,420,155 (New Position) | View |
2021-02-12 8:00 pm Unchanged | 13G | ABCELLERA BIOLOGICS INC. ABCL | VIKING GLOBAL INVESTORS LP | 19,283,744 7.2% | 0 (Unchanged) | View |
2021-02-12 7:58 pm Unchanged | 13G | 4D Molecular Therapeutics Inc. FDMT | VIKING GLOBAL INVESTORS LP | 3,937,914 14.9% | 0 (Unchanged) | View |
2021-02-12 7:55 pm Unchanged | 13G | Athira Pharma Inc. ATHA | VIKING GLOBAL INVESTORS LP | 2,120,653 6% | 0 (Unchanged) | View |
2021-02-12 7:52 pm Sale | 13G | Zentalis Pharmaceuticals Inc. ZNTL | VIKING GLOBAL INVESTORS LP | 3,011,284 7.4% | -1,432,000 (-32.23%) | View |
2021-02-12 7:50 pm Sale | 13G | PMV PHARMACEUTICALS INC PMVP | VIKING GLOBAL INVESTORS LP | 2,364,062 5.3% | -277,778 (-10.51%) | View |
2021-02-12 7:43 pm Purchase | 13G | Inhibrx Inc. INBX | VIKING GLOBAL INVESTORS LP | 5,305,866 14.1% | 180,219 (+3.52%) | View |
2021-02-12 7:41 pm Sale | 13G | GoHealth Inc. GOCO | VIKING GLOBAL INVESTORS LP | 2,600,905 3.1% | -1,958,187 (-42.95%) | View |
2021-02-12 7:38 pm Purchase | 13G | Adaptive Biotechnologies Corp ADPT | VIKING GLOBAL INVESTORS LP | 29,993,708 21.9% | 13,611,045 (+83.08%) | View |
2021-02-12 7:36 pm Sale | 13G | Change Healthcare Inc. CHNG | VIKING GLOBAL INVESTORS LP | 0 0% | -7,852,973 (Position Closed) | View |
2021-02-12 7:34 pm Sale | 13G | Vertex Inc. VERX | VIKING GLOBAL INVESTORS LP | 0 0% | -1,852,269 (Position Closed) | View |
2021-02-12 7:31 pm Sale | 13G | Chewy Inc. CHWY | VIKING GLOBAL INVESTORS LP | 0 0% | -2,896,423 (Position Closed) | View |
2021-02-12 7:29 pm Sale | 13G | ATYR PHARMA INC LIFE | VIKING GLOBAL INVESTORS LP | 0 0% | -816,728 (Position Closed) | View |
2021-02-12 7:27 pm Sale | 13G | CANADA GOOSE HLDGS INC SHS SUB GOOS | VIKING GLOBAL INVESTORS LP | 0 0% | -3,033,186 (Position Closed) | View |
2021-02-12 1:09 pm Sale | 13G | Nuance Communications Inc. SSFT | VIKING GLOBAL INVESTORS LP | 16,382,663 5.8% | -22,023,944 (-57.34%) | View |